Glucotrack (GCTK) Interest Expenses (2013 - 2024)

Glucotrack (GCTK) recorded quarterly Interest Expenses of $5000.0 in Q3 2024, up 400.0% on a QoQ basis from $1000.0 in Q3 2022.

Glucotrack (GCTK) Interest Expenses (2013 - 2024) Analysis & Trends

Glucotrack has disclosed Interest Expenses across 7 years of filings, most recently posting $5000.0 for Q3 2024.

Quarterly Interest Expenses changed N/A year-over-year to $5000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $5000.0 (changed N/A YoY) and the FY2015 annual result came in at $15205.0, up 794.61% from the prior year.
Interest Expenses improved to $5000.0 in Q3 2024, from $1000.0 in the prior quarter.
Over five years, Interest Expenses peaked at $5000.0 in Q3 2024 and troughed at $1000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	149.00 Mn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	1.90 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	20.90 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Glucotrack	4.26	-7.38 Mn	-	-

Download Data